Facebook Linkedin RSS Twitter Youtube
Home 2024

Late-stage clinical drug development

Illumina’s Jacob Thaysen Describes His First Year as CEO
Insights

Illumina’s Jacob Thaysen Describes His First Year as CEO

Mirai Bio Founded to Provide Fully Integrated End-to-End Genetic Medicine Development
Bioprocessing

Mirai Bio Founded to Provide Fully Integrated End-to-End Genetic Medicine Development

Animal Models Aren’t Human!
Drug Discovery

Animal Models Aren’t Human!

Neuropeptides Found to Encode Danger in the Brain
News

Neuropeptides Found to Encode Danger in the Brain

Base Editing Tweaks Mouse Gut Microbiome, in Scientific First
GEN Edge

Base Editing Tweaks Mouse Gut Microbiome, in Scientific First

Endpoints: Considerations for Hit to Lead Selection of a Bispecific Antibody in Oncology
Cancer

Endpoints: Considerations for Hit to Lead Selection of a Bispecific Antibody in Oncology

Endpoints: Critical Preclinical Markers in Neurodegeneration Disease Assays
Drug Discovery

Endpoints: Critical Preclinical Markers in Neurodegeneration Disease Assays

Biologics Drug Development Gets an Upgrade with Humanized Animal Models
Drug Discovery

Biologics Drug Development Gets an Upgrade with Humanized Animal Models

In Vivo Gene Editing Grants Access to Medical Treasures
Genome Editing

In Vivo Gene Editing Grants Access to Medical Treasures

Customized mRNA Processing for Improved Therapy Development and Manufacturing
Drug Discovery

Customized mRNA Processing for Improved Therapy Development and Manufacturing

123...17Page 1 of 17
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.